Preclinical study demonstrates neuroprotection and extended lifespan in a Caenorhabditis elegans model, suggesting the therapeutic promise of hydrogen sulfide-releasing rivastigmine hybrids.
S), a gasotransmitter with a key role in the neurological physiology of ageing. In particular, we identified compound 1, as a potent small molecule capable of inhibit AChE, preventing inflammation and ROS production in cultured neurons and microglia, triggering autophagy response and blocking Aβ fibrils propagation. Interestingly, the beneficial effects observed in vitro have been confirmed in vivo, since the rivastigmine derivative 1 improved the lifespan in a Caenorhabditis elegans model of AD.
No takes yet. Share an insight, caveat, or question.
Sestito et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: